Honghe Wang

Honghe Wang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2023 in Advanced Composites and Hybrid Materials
Verified
Journal Article
Open access
PDF file
SSShatila Sarwar
Shatila Sarwar
MLMao-Chia Lin
Mao-Chia Lin
CACarolina Amezaga
Carolina Amezaga
ZWZhen Wei
Zhen Wei
EIEtinosa Iyayi
Etinosa Iyayi
Xinyu ZhangXinyu Zhang
Xinyu Zhang
The coronavirus disease 2019 (COVID-19) is a highly contagious and fatal disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In general, the diagnostic tests for COVID-19 are based on the detection of nucleic acid, antibodies, and protein. Among different analytes, the gold standard of the COVID-19 test is the viral nucleic acid detection performed by the quantitative reverse transcription polymerase chain reaction (qRT-PCR) method. However, the gold standard test is time-consuming and requires expensive instrumentation, as well as trained personnel. Herein, we report an ultrasensitive electrochemical biosensor based on zinc sulfide/graphene (ZnS/graphene) nanocomposite for rapid and direct nucleic acid detection of SARS-CoV-2. We demonstrated a simple one-step route for manufacturing ZnS/graphene by employing an ultrafast (90 s) microwave-based non-equilibrium heating approach. The biosensor assay involves the hybridization of target DNA or RNA samples with probes that are immersed into a redox active electrolyte, which are detectable by electrochemical measurements. In this study, we have performed the tests for synthetic DNA samples and, SARS-CoV-2 standard samples. Experimental results revealed that the proposed biosensor could detect low concentrations of all different SARS-CoV-2 samples, using such as S, ORF 1a, and ORF 1b gene sequences as targets. This microwave-synthesized ZnS/graphene-based biosensor could be reliably used as an on-site, real-time, and rapid diagnostic test for COVID-19.

13 April 2023 in Cancers
Verified
Journal Article
Open access
PDF file
SAShakir Uddin Ahmed
Shakir Uddin Ahmed
BLBrittany D. Lord
Brittany D. Lord
BABenjamin Adu Addai
Benjamin Adu Addai
SSSandeep K Singhal
Sandeep K Singhal
KGKevin L. Gardner
Kevin L. Gardner
CYClayton Yates
Clayton Yates
African American (AA) women with breast cancer are more likely to have higher inflammation and a stronger overall immune response, which correlate with poorer outcomes. In this report, we applied the nanostring immune panel to identify differences in inflammatory and immune gene expression by race. We observed a higher expression of multiple cytokines in AA patients compared to EA patients, with high expression of CD47, TGFB1, and NFKB1 associated with the transcriptional repressor Kaiso. To investigate the mechanism associated with this expression pattern, we observed that Kaiso depletion results in decreased expression of CD47, and its ligand SIRPA. Furthermore, Kaiso appears to directly bind to the methylated sequences of the THBS1 promotor and repress gene expression. Similarly, Kaiso depletion attenuated tumor formation in athymic nude mice, and these Kaiso-depleted xenograft tissues showed significantly higher phagocytosis and increased infiltration of M1 macrophages. In vitro validation using MCF7 and THP1 macrophages treated with Kaiso-depleted exosomes showed a reduced expression of immune-related markers (CD47 and SIRPA) and macrophage polarization towards the M1 phenotype compared to MCF7 cells treated with exosomes isolated from high-Kaiso cells. Lastly, analysis of TCGA breast cancer patient data demonstrates that this gene signature is most prominent in the basal-like subtype, which is more frequently observed in AA breast cancer patients.

10 August 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
JMJoakin O. Mori
Joakin O. Mori
JWJason White
Jason White
IEIsra Elhussin
Isra Elhussin
BDBabatunde M. Duduyemi
Babatunde M. Duduyemi
BKBalasubramanyam Karanam
Balasubramanyam Karanam
HWHonghe Wang
Honghe Wang
Prostate cancer (PCa) disproportionately affects African American (AA) men, yet present biomarkers do not address the observed racial disparity. The objective of this study was to identify biomarkers with potential benefits to AA PCa patients. Differentially expressed genes (DEG) analysis coupled with gene set enrichment analysis (GSEA) and leading-edge genes analysis showed that the keratin family of genes, including KRT8, KRT15, KRT19, KRT34, and KRT80, constituted the single most prominent family of genes enriched in AA compared to European American (EA) PCa cell lines. In PCa patients (TCGA and MSKCC patient cohorts), KRT8, KRT15, and KRT19 expression were relatively higher in AA than in EA patients. The differences in the expression of KRT15 and KRT19, but not KRT8, were enhanced by Gleason score and ERG fusion status; in low Gleason (Gleason ≤ 6 [TCGA cohort] and Gleason ≤ 7 [MSKCC cohort]), the expression of KRT15 and KRT19 was significantly (p ≤ 0.05) higher in AA than in EA patients. Survival analysis revealed that high expression of KRT15 and KRT19 was associated with increased risk of biochemical recurrence in low Gleason category patients in the TCGA patient cohort. Interestingly, KRT15 and KRT19 expression were also associated with an increased risk of death in the metastatic prostate adenocarcinoma cohort, suggesting the potential to predict the risks of disease recurrence and death in the low Gleason category and advanced disease conditions respectively. Gene set enrichment analysis revealed known oncogenic gene signatures, including KRAS and ERBB2, to be enriched in patients expressing high KRT15 and KRT19. Furthermore, high KRT15 and KRT19 were linked to the basal and LumA PCa subtypes, which are associated with poor postoperative androgen deprivation therapy (ADT) response compared to the LumB subtype. Taken together, the present study identifies genes with high expression in AA than in EA PCa. The identified genes are linked to oncogenic gene signatures, including KRAS and ERBB2, and to basal and LumA PCa subtypes that are associated with poor postoperative ADT response. This study, therefore, reveals biomarkers with the potential to address biomarker bias in PCa risk stratification and/or prognosis.

1 January 2025 in Journal of Applied Biology & Biotechnology
Verified
Journal Article
Open access
PDF file
ASArchana Sharma
Archana Sharma
HPHaseena Polk
Haseena Polk
EIEtinosa Iyayi
Etinosa Iyayi
HLHuixian Lin
Huixian Lin
HWHonghe Wang
Honghe Wang
Sexually transmitted infections are linked to increased risk of some cancers, with chronic inflammation and persistent infections accounting for roughly 20% of cancer cases worldwide. Early detection of these pathogens can help prevent cancer development or progression. This study focused on Human Immunodeficiency Virus-1, Human Papilloma Virus-16, and Epstein-Barr Virus, known to increase cancer risk. A simple colorimetric and reverse transcription Loop-Mediated Isothermal Amplification (LAMP) assay was developed and standardized for rapid detection of these pathogens. The amplification can be visually detected based on color changes. Specifically designed primers targeting conserved genes of HIV-1, EBV, and HPV-16 were analyzed for their specificity and limit of detection. No cross-reactivity was noticed with other pathogenic RNAs and primer sets displayed 100% specificity to their respective pathogenic RNA. We were able to detect as low as 4 RNA copies per reaction within a brief period of 25 minutes. LAMP amplifies a target nucleic acid sequence under isothermal conditions, requiring only basic equipment like a water bath or heating block. Our results show that LAMP’s simplicity and reliability make it ideal for point-of-need (PON) use, with its early detection of cancer-related pathogens offering significant potential for cancer prevention, public health education, and interventions.

14 November 2025 in Metabolites
Verified
Journal Article
Open access
PDF file
MHMariline Hilaire
Mariline Hilaire
BGBrandon Gines
Brandon Gines
WCWillard Collier
Willard Collier
HWHonghe Wang
Honghe Wang
SCSantosh Chaudhary
Santosh Chaudhary
BMByeng R. Min
Byeng R. Min
Background/Objectives: Animal health remains a critical issue that directly impacts economic sustainability through animal welfare and production. In small ruminants, the gastrointestinal parasite Haemonchus contortus can lead to anemia and possibly mortality, since parasite burden can be considerable and is challenging to control. Small ruminant health can be affected by poor diet and environmental conditions that lead to changes in the metabolic balance. The link between animal health and metabolic profiles has been investigated in the past. These studies have shed important light on physiological changes by identifying dietary and disease biomarkers. This study aimed to correlate the metabolite signature of feces from goats, having two levels of Haemonchus contortus infection, grazing on two different forages (Bermudagrass and Sunn Hemp). Methods: Fecal samples were taken from goats grazing either Sunn Hemp or Bermudagrass pastures, with naturally variable Haemonchus contortus loads. Samples were evaluated using 1H-NMR and LC/MS methods to describe and compare metabolic patterns under varied forage conditions between low and high Fecal Egg Count (FEC). Results: Our findings indicated no significant difference using univariate analyses but identified 10 discriminatory features using multivariate analyses for Bermudagrass and Sunn Hemp using 1H-NMR. With LC-MS, we found 14 significantly different features (p < 0.05, FC > 2), 115 discriminatory features for Bermudagrass and 113 in Sunn Hemp from multivariate analyses. Combining the findings of the two approaches suggested that Haemonchus contortus influenced several pathways associated with the metabolism of amino acids and energy conversion. Conclusions: The analysis of metabolome changes across both forages may help in revealing novel knowledge and accurate identification of possible biomarkers for gastrointestinal parasites. Further study is needed to validate the potential biomarker before deploying diagnostic tools based on the metabolomics indicators for early parasite diagnosis.

27 July 2022 in Preprints.org
Verified
Preprint
Open access
PDF file
CYClayton Yates
Clayton Yates
AAAnusha Angajala
Anusha Angajala
Aliyu MuhammadAliyu Muhammad
Aliyu Muhammad
HRHughley Raymond
Hughley Raymond
SAShakir Md Ahmed
Shakir Md Ahmed
WDWindy Dean-Colomb
Windy Dean-Colomb
Background: We previously found that QNBC tumors are more frequent in African Americans compared to TNBC tumors. To characterize this subtype further, we sought to determine the miRNA-mRNA profile in QNBC patients based on race. Methods: Both miRNA and mRNA expression data were analyzed from TCGA and validated using datasets from the METABRIC, TCGA proteomic, and survival analysis by KMPLOT. Results: miRNA-mRNAs which include FOXA1 and MYC (mir-17/20a targets); GATA3 and CCNG2 (mir-135b targets); CDKN2A, CDK6, and B7-H3 (mir-29c targets); and RUNX3, KLF5, IL1-β, and CTNNB1 (mir-375 targets) were correlated with basal-like and immune subtypes in QNBC patients and associated with a worse survival. Conclusion: Thus, QNBC tumors have an altered gene signature implicated in racial disparity and poor survival.